相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Platinum-Based Modification of Styrylbenzylsulfones as Multifunctional Antitumor Agents: Targeting the RAS/RAF Pathway, Enhancing Antitumor Activity, and Overcoming Multidrug Resistance
Zhikun Liu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2020)
A Dogma in Doubt: Hydrolysis of Equatorial Ligands of PtIV Complexes under Physiological Conditions
Alexander Kastner et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2019)
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer
Maurizio Sabbatini et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Permeability prediction for zwitterions via chromatographic indexes and classification into 'certain' and 'uncertain'
Francesco Caudana et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Drug permeability profiling using cell-free permeation tools: Overview and applications
Philippe Berben et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Charged cyclic hexapeptides: Updating molecular descriptors for permeability purposes
G. Ermondi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Learning how to use IAM chromatography for predicting permeability
Giuseppe Ermondi et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)
Impact of Dynamically Exposed Polarity on Permeability and Solubility of Chameleonic Drugs Beyond the Rule of 5
Matteo Rossi Sebastiano et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
A new platinum-based prodrug candidate: Its anticancer effects in B50 neuroblastoma rat cells
Beatrice Rangone et al.
LIFE SCIENCES (2018)
Leveraging chromatography based physicochemical properties for efficient drug design
Gilles H. Goetz et al.
ADMET AND DMPK (2018)
Histone Deacetylase Inhibitors as Anticancer Drugs
Tomas Eckschlager et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Interstrand Crosslink Repair as a Target for HDAC Inhibition
Teodora Nikolova et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2017)
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl) octanoate: a very efficient multi-action antitumor prodrug candidate
Elisabetta Gabano et al.
DALTON TRANSACTIONS (2017)
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
Timothy C. Johnstone et al.
CHEMICAL REVIEWS (2016)
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs
Mauro Ravera et al.
DALTON TRANSACTIONS (2016)
Pt(IV) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action
Raji Raveendran et al.
CHEMICAL SCIENCE (2016)
New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells
Vojtech Novohradsky et al.
BIOCHEMICAL PHARMACOLOGY (2015)
A Review of the Evolution of Systemic Chemotherapy in the Management of Colorectal Cancer
Bengt Gustavsson et al.
CLINICAL COLORECTAL CANCER (2015)
On the Stability of PtIV Pro-Drugs with Haloacetato Ligands in the Axial Positions
Ezequiel Wexselblatt et al.
CHEMISTRY-A EUROPEAN JOURNAL (2015)
Synthetic Methods for the Preparation of Platinum Anticancer Complexes
Justin J. Wilson et al.
CHEMICAL REVIEWS (2014)
Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands
Vojtech Novohradsky et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2014)
Distinguishing between the Permeability Relationships with Absorption and Metabolism To Improve BCS and BDDCS Predictions in Early Drug Discovery
Caroline A. Larregieu et al.
MOLECULAR PHARMACEUTICS (2014)
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Katrina J. Falkenberg et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Platinum(IV) Prodrugs with Haloacetato Ligands in the Axial Positions can Undergo Hydrolysis under Biologically Relevant Conditions
Ezequiel Wexselblatt et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
Molecular interaction fields vs. quantum-mechanical-based descriptors in the modelling of lipophilicity of platinum(IV) complexes
Giuseppe Ermondi et al.
DALTON TRANSACTIONS (2013)
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells
Manuela Alessio et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2013)
Epigenetic and genetic features of 24 colon cancer cell lines
D. Ahmed et al.
ONCOGENESIS (2013)
Redox activation of metal-based prodrugs as a strategy for drug delivery
Nora Graf et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
What do we know about the reduction of Pt(IV) pro-drugs?
Ezequiel Wexselblatt et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2012)
Revisiting [PtCl2(cis-1,4-DACH)]: An Underestimated Antitumor Drug with Potential Application to the Treatment of Oxaliplatin-Refractory Colorectal Cancer
Nicola Margiotta et al.
JOURNAL OF MEDICINAL CHEMISTRY (2012)
Conjugate of Pt(IV)-Histone Deacetylase Inhibitor as a Prodrug for Cancer Chemotherapy
Jun Yang et al.
MOLECULAR PHARMACEUTICS (2012)
Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes
James A. Platts et al.
JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY (2011)
Valproic Acid in the Complex Therapy of Malignant Tumors
J. Hrebackova et al.
CURRENT DRUG TARGETS (2010)
Rational Combinations Using HDAC Inhibitors
Michael Bots et al.
CLINICAL CANCER RESEARCH (2009)
Conformer distribution in (cis-1,4-DACH)bis(guanosine-5′-phosphate)platinum(II) adducts:: A reliable model for DNA adducts of antitumoral cisplatin
Rosa Ranaldo et al.
INORGANIC CHEMISTRY (2008)
A novel design of artificial membrane for improving the PAMPA model
Xiaoxi Chen et al.
PHARMACEUTICAL RESEARCH (2008)
Epigenetic therapy of cancer: past, present and future
CB Yoo et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Application of high-performance liquid chromatography based measurements of lipophilicity to model biological distribution
K Valkó
JOURNAL OF CHROMATOGRAPHY A (2004)
A practical synthesis of optically active (R)-2-propyloctanoic acid:: Therapeutic agent for Alzheimer's disease
T Hasegawa et al.
BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN (2000)
分享论文
